KOR

e-Article

A phase II study of CI-973 [SP-4-3(R)]-[1,1-cyclobutane-dicarboxylato (2-)](2-methyl-1,4-butanediamine-N,N')platinum in patients with refractory advanced breast cancer
Document Type
Journal
Source
CANCER CHEMOTHERAPY AND PHARMACOLOGY; JUL 1996, 38 3, p289-p291, 3p.
Subject
Language
English
ISSN
03445704